New Analysis Links Wegovy to a Rare Eye Condition That Can Cause Sudden, Permanent Vision Loss
A March 2026 analysis of 30M+ FDA adverse event reports found Wegovy's NAION eye stroke signal was nearly 5x stronger than Ozempic's. Vision loss may be sudden and permanent.
Read the full articleYou might also wanna read
Researchers Find Small Increased Risk of Sudden Vision Loss Associated With GLP-1 Medications
A medication commonly used to treat Type 2 diabetes and obesity was associated with a slight increase in risk for a rare condition involving
GLP-1 Receptor Agonists and Eye Safety: Examining the NAION Risk at ADA 2025
Do their associations with nonarteritic anterior ischemic optic neuropathy and other adverse outcomes make these drugs more risky than benef
mdsc.pe·18h agoLarge Swedish Study Suggests Low Overall Risk of Sudden Vision Loss with GLP-1 RA Use
A nationwide cohort study found a slightly higher risk for nonarteritic anterior ischemic optic neuropathy (NAION) among users of glucagon-l
The Ozempic and Wegovy mistake sending thousands to poison control
Poison control calls involving semaglutide (Ozempic and Wegovy) soared after the drug was approved for weight management, with researchers l
Wegovy's Canadian Launch and AI's Role in Accelerating Weight Drug Discovery
AI is accelerating the development of new weight management drugs like Wegovy, promising faster discovery cycles and personalized therapies.
startuphub.ai·16d agoU.S. Study Suggests GLP-1 RA Drugs Are Associated with Small Increase in Ischemic Optic Neuropathy
A target trial emulation found that people with type 2 diabetes who start glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy had a s
Comments
Sign in to join the conversation.
No comments yet. Be the first.